The laboratory focuses on the determination of molecular mechanisms responsible for diseases involving erythroid cells. We apply a variety of laboratory and bioinformatic approaches to the study of human blood stem and progenitor cells. Molecular and genomic studies from the laboratory are then correlated with clinical data for disease prevention or the development of genetic and pharmaceutical therapies.
We need to know exactly how blood is normally made, and what goes wrong to cause anemia in millions of people. With that information, we will be able to identify and develop new therapies for those people.